1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.
6He L,Hannon GJ.MicroRNAs:small RNAs with a big role in gene regulation.Nat Rev Genet,2004,5:522-531.
7Zhang B,Pan X,Cobb GP,et al.MicroRNAs as oncogenes and tumor suppressors.Dev Biol,2007,302:1-12.
8Takagi T,Iio A,Nakagawa Y,et al.Decreased expression of microRNA-143 and-145 in human gastric cancers.Oncology,2009,77:12-21.
9Chiyomaru T,Enokida H,Tatarano S,et al.MiR-145 and miR-133a function as tumour suppressors and directly regulate FSCNI expression in bladder cancer.Br J Cancer,2010,102:883-891.
10Sachdeva M,Zhu S,Wu F,et al.P53 represses c-Myc through induction of the tumor suppressor miR-145.Proc Natl Acad Sci USA,2009,106:3207-3212.
